209 related articles for article (PubMed ID: 32754804)
1. Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes.
Hannelius U; Beam CA; Ludvigsson J
Diabetologia; 2020 Oct; 63(10):2177-2181. PubMed ID: 32754804
[TBL] [Abstract][Full Text] [Related]
2. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.
Törn C; Gupta M; Nikitina Zake L; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2003 Sep; 64(9):902-9. PubMed ID: 12941547
[TBL] [Abstract][Full Text] [Related]
3. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
Nowak C; Lind M; Sumnik Z; Pelikanova T; Nattero-Chavez L; Lundberg E; Rica I; Martínez-Brocca MA; Ruiz de Adana M; Wahlberg J; Hanas R; Hernandez C; Clemente-León M; Gómez-Gila A; Ferrer Lozano M; Sas T; Pruhova S; Dietrich F; Puente-Marin S; Hannelius U; Casas R; Ludvigsson J
J Clin Endocrinol Metab; 2022 Aug; 107(9):2644-2651. PubMed ID: 35665810
[TBL] [Abstract][Full Text] [Related]
4. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings.
Gillespie KM; Aitken RJ; Wilson I; Williams AJ; Bingley PJ
Diabetes; 2014 Mar; 63(3):1041-7. PubMed ID: 24203724
[TBL] [Abstract][Full Text] [Related]
5. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes.
Undlien DE; Kockum I; Rønningen KS; Lowe R; Saanjeevi CB; Graham J; Lie BA; Akselsen HE; Lernmark A; Thorsby E
Tissue Antigens; 1999 Dec; 54(6):543-51. PubMed ID: 10674967
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
8. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
9. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
[TBL] [Abstract][Full Text] [Related]
11. Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol.
Ludvigsson J; Eriksson L; Nowak C; Teixeira PF; Widman M; Lindqvist A; Casas R; Lind M; Hannelius U
BMJ Open; 2022 Oct; 12(10):e061776. PubMed ID: 36316084
[TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
13. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease.
Smigoc Schweiger D; Mendez A; Kunilo Jamnik S; Bratanic N; Bratina N; Battelino T; Brecelj J; Vidan-Jeras B
Autoimmunity; 2016 Jun; 49(4):240-7. PubMed ID: 27138053
[TBL] [Abstract][Full Text] [Related]
14. HLA-DQ associations in type 1 autoimmune hepatitis.
Czaja AJ; Santrach PJ; Moore SB
Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
[TBL] [Abstract][Full Text] [Related]
15. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
16. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
[TBL] [Abstract][Full Text] [Related]
17. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
[TBL] [Abstract][Full Text] [Related]
18. Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease.
Verhagen J; Yusuf N; Smith EL; Whettlock EM; Naran K; Arif S; Peakman M
Diabetologia; 2019 Dec; 62(12):2252-2261. PubMed ID: 31612266
[TBL] [Abstract][Full Text] [Related]
19. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
[TBL] [Abstract][Full Text] [Related]
20. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.
Pani MA; Van Autreve J; Van der Auwera BJ; Gorus FK; Badenhoop K
Diabetologia; 2002 Sep; 45(9):1340-3. PubMed ID: 12242468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
